Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Okada

Showing results (441-450 of 443) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 443 results.
Cell|June 17, 2021
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesYafei Liu, Wai Tuck Soh, Jun-Ichi Kishikawa, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
Cell|April 30, 2021
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseasesMineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, et al.
Pageof 45

Showing results (441-450 of 443) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 443 results.
Cell|June 17, 2021
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesYafei Liu, Wai Tuck Soh, Jun-Ichi Kishikawa, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
Cell|April 30, 2021
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseasesMineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, et al.
Pageof 45